News from Crescent and our Investees
‘Dolly the Sheep’ Business Mastermind Joins Digital Pathology Company
PathXL welcomes one of UK’s leading medtech minds onto their Board One of the leading names in the UK’s... Find Out More
PathXL provide digital microscopy systems for Molecular Pathology Laboratory and Biobank.
BELFAST, NORTHERN IRELAND, 9 January 2013: Crescent Capital’s PathXL is proud to be involved with the Northern Ireland Biobank... Find Out MorePathXL investment clinches Deal of the Month
BELFAST, NORTHERN IRELAND, 2 January 2013: The seven-figure sum investment in medical technology company, PathXL, a Crescent Capital portfolio company, has been named... Find Out More
Seven figure investment announced by Belfast software pioneer PathXL
Digital pathology company to expand cancer research & diagnosis support products BELFAST, NORTHERN IRELAND, 13 December 2012: PathXL, a... Find Out MoreFrost & Sullivan Honours PathXL with Enabling Technology Award
PathXL Recognised for its Pioneering Digital Pathology Solutions LONDON, April 19, 2012 /PRNewswire/ — Based on its recent analysis of web-based software... Find Out More